The Fiendishness of Fentanyl
Dates: August 7, 2026
Meets: F from 9:00 AM to 10:00 AM
Location: Zoom Webinar
Zoom - No Charge: $0.00
There are still openings remaining at this time.
Our medical team will discuss how fentanyl use has contributed to excess overdose deaths. This discussion will also include an explanation of how the increased use of this high potency opioid has necessitated some changes in our prior MOUD practices, such as induction of buprenorphine and total dose used. Attention will also be called to the importance of integrating harm reduction practices into the care of patients with fentanyl use disorder, including naloxone prescribing, clean needle distribution, and fentanyl test strip distribution.
Objectives:
- Review the uniquely fatal nature of fentanyl use disorder.
- Learn about how modifications to typical MOUD protocols maybe more effective in this population.
Notes:
This event is subject to priority registration. If you have a code, you may register yourself now. If you do not have a registration code, please add yourself to the waitlist. Any registration spots avilable after the priority registration period is over will be awarded on a first-come first-served basis for those on the waitlist.
Certificates for this event are distributed by Hazelden Betty Ford Foundation upon completion of a post-event quiz and evaluation.
If you have any questions about this event, please email learn@midsouth.ualr.edu.
| Fee: | $0.00 |
|---|---|
| Hours: | 1.00 |
Zoom Webinar
Emily Brunner
MD, DFASAM, Physician, TTA Consultant
Dr. Emily Brunner is both certified in family medicine and a distinguished fellow in the field of addiction medicine. She has experience treating addiction in both inpatient and outpatient settings. She is an experienced speaker and specializes in trauma-informed clinical treatment of substance use disorders with a comprehensive and compassionate approach.
Dr. Brunner has been involved in leadership of the Minnesota Society of Addiction Medicine and is now on the national board of the American Society of Addiction Medicine.

